Acute Coronary SyndromePhase 3COGENT-1NCT00557921
Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1)
A Phase 3 study testing CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin and Plavix (clopidogrel 75 mg) and aspirin in people with Acute Coronary Syndrome and Myocardial Infarction, run by Cogentus Pharmaceuticals at 491 sites in 16 countries.
Trial summary
The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of gastrointestinal bleeding and symptomatic ulcer disease, in the setting of concomitant aspirin therapy. Read more about this study
- Who is it for?
- Ages 21 years and older
- Conditions the study is for
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease
- What is being tested?
- CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin and Plavix (clopidogrel 75 mg) and aspirin
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 5,000 participants
- Where
- 491 sitesin 16 countries
- Study dates
- Dec 2007to Nov 2009
- Phase
- Phase 3
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Patients in whom a requirement for clopidogrel therapy with concomitant aspirin is anticipated for at least the next 12 months. Specific conditions that may confer a need for long-term clopidogrel + aspirin therapy may include non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI), ST segment elevation acute MI), or new placement of a coronary artery stent.
- For women of childbearing potential, negative pregnancy test prior to randomization and agreement to use effective method of birth control during the study.
- Able to provide written informed consent based on competent mental status.
Who cannot join
- Patients currently hospitalized for whom discharge is not anticipated within 48 hours of randomization.
- Requirement for current or chronic use of a proton pump inhibitor, H2 receptor blocker, sucralfate or misoprostol.
- Erosive esophagitis, esophageal or gastric variceal disease, or non-endoscopic gastric surgery. Patients with a history of GERD/erosive esophagitis or dyspepsia who do not currently require proton pump blockers will be eligible.
- Receipt of > 21 days of clopidogrel or another thienopyridine prior to randomization.
- Oral anticoagulation that cannot be safely discontinued for duration of study.
- Recent fibrinolytic therapy.
Show all 17Show fewer
- Scheduled percutaneous coronary intervention (PCI). Patients may be enrolled upon completion of PCI.
- Recent (< 30 days prior to randomization) or scheduled coronary artery bypass graft (CABG) surgery.
- Cardiogenic shock at time of randomization, refractory ventricular arrhythmias, or congestive heart failure (NY Heart Association class IV).
- Active pathological bleeding or a history of hereditary or acquired hemostatic disorder.
- History of hemorrhagic stroke, intracranial neoplasm, arteriovenous malformation or aneurysm.
- Systemic corticosteroids except low-dose oral corticosteroids equivalent to prednisone < or equal to 5 mg/day.
- Allergy or contraindication to clopidogrel or other thienopyridine drugs, omeprazole or other proton pump inhibitor drugs, aspirin or salicylate derivatives, or other study drug ingredients.
- Treatment within 30 days prior to randomization with any investigational drug or device including investigational coronary artery stents or currently enrolled in another interventional drug or device study.
- Women who are pregnant or breastfeeding.
- Life expectancy less than 12 months.
- Laboratory abnormality at screening that is clinically significant or outside protocol-allowed limits, or any other condition that precludes participation in the study in the opinion of the Investigator.
Trial locations and contacts
491 sites in 16 countries.
491 sites in 16 countries
United States247 sites
Abington Medical Specialists
Abington, Pennsylvania, 19001
Capital Cardiology Associates
Albany, New York, 12211
Alabama Clinical Research Institute, Inc. (ACRI)
Alexander City, Alabama, 35010
Cardiology Consultants of Orange County
Anaheim, California, 92801
Chest and Critical Care Consultants, A Medical Group
Anaheim, California, 92801
Community Clinical Research Center
Anderson, Indiana, 46011
Family Health Care Assoc.
Arlington, Texas, 76013
Clinical Study Center of Asheville, LLC
Asheville, North Carolina, 28803
Cumberland Cardiology
Ashland, Kentucky, 41101
McMinn Medical Group (DBA: Athens Medical Group)
Athens, Tennessee, 37303
Piedmont Hospital
Atlanta, Georgia, 30309
Primary Care Specialists, LLC/ ECAST CT
Atlanta, Georgia, 30312
Executive Health and Research Associates, Inc.
Atlanta, Georgia, 30342
Maine Research Associates
Auburn, Maine, 04210
American Health Network
Avon, Indiana, 46123
Good Samaritan Hospital (Medstar Health)
Baltimore, Maryland, 21239
Bluestem Cardiology Research Dept.
Bartlesville, Oklahoma, 74006
Verzosa & Ungab Internal Medicine Associates
Bartlett, Tennessee, 38134
Dolby Research, LLC
Baton Rouge, Louisiana, 33437
Michigan Cardiovascular Institute
Bay City, Michigan, 48708
Southeast Texas Clinical Research Center
Beaumont, Texas, 77702
Tri-State Medical Group
Beaver, Pennsylvania, 15009
Bend Memorial Clinic
Bend, Oregon, 97701
Alabama Clinical Therapeutics, LLC
Birmingham, Alabama, 35126
Cardio-Thoracic Surgeons P.C.
Birmingham, Alabama, 35213
Birmingham Heart Clinic, PC
Birmingham, Alabama, 35235
St. Alexius Medical Center
Bismarck, North Dakota, 58501
George G. Ellis, Jr. M.D., Inc.
Boardman, Ohio, 44512
Connecticut Clinical Research
Bridgeport, Connecticut, 06606
Clinical Solutions Advantage
Buena Park, California, 90620
Daniel W. Gottlieb, MD, PS
Burien, Washington, 98166
Kernodle Clinic, Inc.
Burlington, North Carolina, 27215
Heritage Cardiology Association
Camp Hill, Pennsylvania, 17011
Cardiovascular Research Institute, LLC
Canton, Ohio, 44710
Trinity Hypertension and Diagnostic Res.
Carrollton, Texas, 75006
Turns Institute for Clinical Research
Castro Valley, California, 94546
Metrolina Medical Research
Charlotte, North Carolina, 28209
Associated Cardiovascular Consultants
Cherry Hill, New Jersey, 08034
PPS Clinical Research, STL, LLC
Chesterfield, Missouri, 63017
Comprehensive Cardiology Consultants, Inc.
Cincinnati, Ohio, 45236
Colorado Springs Health Partners
Colorado Springs, Colorado, 80907
Southeast Regional Research Group
Columbus, Georgia, 31904
Midwest Cardiology Research Foundation
Columbus, Ohio, 43214
Oscar R. Guerra, MD PA
Coral Gables, Florida, 33134
Hudson Valley Cardiology Group, P.C.
Cortlandt Manor, New York, 10567
Georgia Heart Specialists, LLC
Covington, Georgia, 30014
New England Center for Clinical Research, Inc
Cranston, Rhode Island, 02920
VA Medical Center
Dallas, Texas, 75216
U.T. Southwestern
Dallas, Texas, 75390
Cardiology Consultants of Danville
Danville, Virginia, 24541
Midwest Cardiovascular Research Foundation
Davenport, Iowa, 52803
Ialum Clinical Research Center, LLC
Decatur, Georgia, 30032
Ialum Clinical Research Center
Decatur, Georgia, 30032
Ialum Clinical Research Center
Decatur, Georgia, 30035
Deerfield Beach Cardiology Associates
Deerfield Beach, Florida, 33442
Duluth Clinic / Saint Marys Medical Center
Duluth, Minnesota, 55805
Diversified Research
Durham, North Carolina, 27704
Premier Heart Specialists
Easton, Pennsylvania, 18042
Indiana Medical Research
Elkhart, Indiana, 46514
Cardiovascular Associates of the Delaware Valley, P.A.
Elmer, New Jersey, 08318
Heart Specialists of Lancaster
Ephrata, Pennsylvania, 17522
Escondido Cardiology Associates
Escondido, California, 92025
Welborn Clinic
Evansville, Indiana, 47713
Cumberland Research Associates, LLC
Fayetteville, North Carolina, 28304
Middle Tennessee Clinical Research
Fayetteville, Tennessee, 37334
Apex Medical Research, AMR, Inc.
Flint, Michigan, 48504
South Suburban Health Professional Group, PC
Flossmoor, Illinois, 60422
Amir Malik Research
Fort Worth, Texas, 76104
Prestige Clinical Research
Franklin, Ohio, 45005
Triad Research Institute
Galax, Virginia, 24333
The University of Texas Medical Branch at Galveston
Galveston, Texas, 77555-0553
John F Simmons , MD PC
Geneva, Alabama, 36340
Altru Health Systems
Grand Forks, North Dakota, 58201
eCast Corporation
Greenbelt, Maryland, 20770
New Coast Cardiology Center, PLLC
Gulfport, Mississippi, 39503
Cardiovascular Associates of the Delaware Valley, P.A.
Haddon Heights, New Jersey, 08035
Dr Jules Cohen
Hallandale, Florida, 33009
Hartford Hospital
Hartford, Connecticut, 06102
Pentucket Medical Associates
Haverhill, Massachusetts, 01830
Penn State Hershey Medical Center
Hershey, Pennsylvania, 17033
Empire International Research
Hialeah, Florida, 33012
Hillsboro Cardiology, PC
Hillsboro, Oregon, 97123
Cardiovascular Consultants of South Florida
Hollywood, Florida, 33021
Clinical Research Consultants, Inc.
Hoover, Alabama, 35216
Tri-Lakes Research
Hot Springs, Arkansas, 71901
Michael A. Frais, Cardiologist, P.A.
Hot Springs, Arkansas, 71913
Cardiovascular Institute of the South
Houma, Louisiana, 70301
East Texas Cardiology PA
Houston, Texas, 77002
Office of Amer Zaheer, MD
Houston, Texas, 77004
Office of Salim Gopalani, MD
Houston, Texas, 77008
Comprehensive Heart Care, PA
Houston, Texas, 77024
Century Clinical Research
Houston, Texas, 77036
Office of Mizra Basith Baig, MD
Houston, Texas, 77055
The Heart Center, PC
Huntsville, Alabama, 35801
Hutchinson Clinic, P.A.
Hutchinson, Kansas, 67502
Indiana Heart Physicians
Indianapolis, Indiana, 46237
Research Associates of Jackson and Apex Cardiology
Jackson, Tennessee, 38301
Jacksonville Heart Center
Jacksonville, Florida, 32207
Jacksonville Center for Clinical Research
Jacksonville, Florida, 32216
Jacksonville Heart Center
Jacksonville, Florida, 32250
Pennsylvania Heart and Vascular Group, P.C.
Jenkintown, Pennsylvania, 19046
Cardiology Associates, P.C.
Johnson City, New York, 13790
Tri-State Cardiology
Johnson City, Tennessee, 37601
NEA-Clinic Cardiology
Jonesboro, Arkansas, 72401
CVMS Resesarch Institute, LLC
Jupiter, Florida, 33458
Borgess Research Institute
Kalamazoo, Michigan, 49048
Glacier View Cardiology
Kalispell, Montana, 59901
Kansas City VA Medical Center
Kansas City, Missouri, 64128
Accurate Clinical Trials, Inc.
Laguna Hills, California, 92653
Therapeutic Research Institute of Orange County
Laguna Hills, California, 92653
Watson Clinic Center for Research
Lakeland, Florida, 33805
Kirtik Thaker MD
Lakewood, California, 90712
Comprehensive Cardiology Consultants
Langhorne, Pennsylvania, 19047
Nevada Cardiology Associates
Las Vegas, Nevada, 89128
Sewickley Valley Medical Group Cardiology
Leetsdale, Pennsylvania, 15056
Los Angeles Cardiology Associates
Los Angeles, California, 90017
Covenant Cardiology Associates
Lubbock, Texas, 79410
Wisconsin Heart, S.C.
Madison, Wisconsin, 53715
Trover Health System
Madisonville, Kentucky, 42431
Heart Clinic of Louisiana Clinical Research, LLC.
Marrero, Louisiana, 70072
South Texas Institutes of Health
McAllen, Texas, 78572
Alpha Medical Research, LLC
Melbourne, Florida, 32901
Consultants in Cardiovascular Medicine
Melrose Park, Illinois, 60160
Memphis Internal Medicine
Memphis, Tennessee, 38119
Goodlife Medical Center
Memphis, Tennessee, 38120
Merced Heart Associates
Merced, California, 95348
Advanced Cardiac Specialists
Mesa, Arizona, 85206
Empire International Research
Miami, Florida, 33125
Suncoast Research Group, LLC
Miami, Florida, 33144
Cardiovascular Research Center of South Florida
Miami, Florida, 33173
Research Center Phase I-IV of Florida Corp.
Miami, Florida, 33175
Empire International Research
Miami, Florida, 33186
Michigan Cardiovascular Institute
Midland, Michigan, 48670
Heart Care Associates, LLC
Milwaukee, Wisconsin, 53215
Long Island Heart Associates
Mineola, New York, 11501
University of Minnesota
Minneapolis, Minnesota, 55455
Trinity Health
Minot, North Dakota, 58701
Venture Resource Group, Inc.
Mission, Kansas, 66202
Mission Internal Medical Group
Mission Viejo, California, 92691
Saint Patrick Hospital- International Heart Institute of Montana
Missoula, Montana, 59802
Mobile Heart Specialists, PC
Mobile, Alabama, 36608
Altos Cardiovascular Associates
Mountain View, California, 94040
Lahey Cardiology @ the Medical Center
Nashua, New Hampshire, 03060
Heart and Vascular Clinic
Nashville, Tennessee, 37203
Charles River Medical Associates
Natick, Massachusetts, 01760
Slocum-Dickson Medical Group, PLLC
New Hartford, New York, 13413
Sound Shore Cardiology, P.C.
New Rochelle, New York, 10801
Bert Fish Medical Center
New Smyrna Beach, Florida, 32168
New York Cardiovascular Associate
New York, New York, 10001
St. Luke's- Roosevelt Hospital
New York, New York, 10025
Alfieri Cardiology, PA
Newark, Delaware, 19713
Cardiology Consultants of Philadelphia
Norristown, Pennsylvania, 19401
Kenneth W. Carr, MD, Cardiology
Oceanside, California, 92056
Oklahoma Cardiovascular Research Group
Oklahoma City, Oklahoma, 73109
The Creighton Cardiac Center
Omaha, Nebraska, 68131
Central Florida Cardiology Group
Orlando, Florida, 32803
Cardiology Assocaites of Orlando d/b/a Orlando Heart Center
Orlando, Florida, 32806
Midwest Cardiology Assocaites
Overland Park, Kansas, 66209
Owensboro Heart and Vascular
Owensboro, Kentucky, 42303
Cardiovascular Care of Northern Carolina
Oxford, North Carolina, 27565
Sunset Point Medical Associates
Palm Harbor, Florida, 34684
Alegent Health Clinic Heart and Vascular Specialist
Papillion, Nebraska, 68046
Parkersburg Cardiology Associates
Parkersburg, West Virginia, 26101
Methodist Medical Center of Illinois
Peoria, Illinois, 61606
Hospital of the University of Pennsylvania Cardiology Department
Philadelphia, Pennsylvania, 19104
Cardiology Consultants of Philadelphia
Philadelphia, Pennsylvania, 19111
Albert Einstein Medical Center
Philadelphia, Pennsylvania, 19141
Cardiology Consultants of Philadelphia
Philadelphia, Pennsylvania, 19148
Redpoint Research
Phoenix, Arizona, 85029
Cardiovascular Consultants, Ltd.
Phoenix, Arizona, 85032
VA Pittsburgh Healthcare System
Pittsburgh, Pennsylvania, 15240
Texas Regional Heart Center d/b/a Legacy Heart Center
Plano, Texas, 75024
Berma Research Group
Plantation, Florida, 33317
Charlotte Heart Group Research Center
Port Charlotte, Florida, 33952
Legacy Clinical Research
Portland, Oregon, 97210
Rhode Island Hospital Cardiology
Providence, Rhode Island, 02903
Rancho CucamongaClinical Trials
Rancho Cucamonga, California, 91703
Virginia Cardiovascular Specialists
Richmond, Virginia, 23226
Rochester General Hospital
Rochester, New York, 14621
Michigan Cardiovascular Institute
Saginaw, Michigan, 48601
Covenant Medical Center, Inc.
Saginaw, Michigan, 48602
Academic Heart and Vascular PLLC
Saint Clair Shores, Michigan, 48081
Regions Hospital
Saint Paul, Minnesota, 55101
Atlantic Cardiology Associates, P.A
Salisbury, Maryland, 21801
Peninsula Cardiology Associates
Salisbury, Maryland, 21804
Heart & Vascular Institute of Texas
San Antonio, Texas, 78217
Cardiology Clinic of San Antonio
San Antonio, Texas, 78229
South Texas Cardiovascular Consultants
San Antonio, Texas, 78229
IMED Research, PA
San Antonio, Texas, 78258
Inland Heart and Vascular Medical Associates
San Bernardino, California, 92404
Ritchken and First
San Diego, California, 92117
Rider Research Group
San Francisco, California, 94117
Richard Levy, MD.
San Francisco, California, 94118
Kaiser Permanente
San Jose, California, 95119
Medical Helping Hands Research
Santa Ana, California, 92704
Pacific Heart Institute
Santa Monica, California, 90404
Radiant Research
Santa Rosa, California, 95405
Saratoga Cardiology Assoc, PC
Saratoga Springs, New York, 12866
Southeast Regional Research Group
Savannah, Georgia, 31406
Cardiovascular Consultants of Maine, PA
Scarborough, Maine, 04074
Westchester Cardiology Associates
Scarsdale, New York, 10583
Advanced Cardiology Specialists
Scranton, Pennsylvania, 18501
Searcy Medical Center
Searcy, Arkansas, 72143
Elite Medical Research, Inc.
Sellersville, Pennsylvania, 18960
Cardiovascular Associates of the Delaware Valley, P.A.
Sewell, New Jersey, 08080
Cochise Clinical Research
Sierra Vista, Arizona, 85635
Maine Cardiology Associates
South Portland, Maine, 04106
Heart Clinic Northwest
Spokane, Washington, 99204
Inland Cardiology Assocaites
Spokane, Washington, 99204
Cardiology Diagnostics, Ltd.
St Louis, Missouri, 63122
Suncoast Cardiovascular Research
St. Petersburg, Florida, 33701
The Heart and Vascular Institute of Florida
St. Petersburg, Florida, 33709
Medsouth Primary CareStockbridge
Stockbridge, Georgia, 30281
Good Samaritan Hospital
Suffern, New York, 10901
Southwest Health Associate, PA
Sugar Land, Texas, 77478
Office of Dwayne O. Williams, MD
Sugarland, Texas, 77479
Palmetto Clinical Research
Summerville, South Carolina, 29485
Cardiology, PC
Syracuse, New York, 13210
SUNY Upstate Medical University
Syracuse, New York, 13210
Franciscan Health System dba FHS Research Center
Tacoma, Washington, 98405
Kings Daughters Clinic
Temple, Texas, 76502
Cardiac Care and Vascular Medicine, Albert Einstein College of Medicine
The Bronx, New York, 10469
St. Vincent Mercy Medical Center
Toledo, Ohio, 43608
Physicans Research Center, LLC
Toms River, New Jersey, 08755
Harbor- UCLA Medical Center
Torrance, California, 90509
Oakland Medical Center
Troy, Michigan, 48085
Capital Cardiology Associates
Troy, New York, 12180
Paradigm Clinical Research, Inc.
Tucson, Arizona, 85705
Cardiology Consultants of Philadelphia
Upland, Pennsylvania, 19013
Ventura Cardiology Consultants Medical Group, Inc.
Ventura, California, 93003
G&G Research Baker-Tombul Cardiology
Vero Beach, Florida, 32960
Victoria Heart and Vascular Center
Victoria, Texas, 77901
Washington V.A. Medical Center
Washington D.C., District of Columbia, 20422
Waterford Medical Assoc. P.C.
Waterford, Michigan, 48328
Northeast Iowa Medical Education Foundation
Waterloo, Iowa, 50702
West Chester Cardiology, PC
West Chester, Pennsylvania, 19380
Cardiology Specialists
Westerly, Rhode Island, 02891
Carlos Levy, D.O.
Weston, Florida, 33326
Buffalo Cardiology and Pulmonary Associates
Williamsville, New York, 14221
Mark J. Kozinn, MD
Williamsville, New York, 14221
Winchester Medical Center/ Clinical Research Department
Winchester, Virginia, 22601
Berks Cardiology, Ltd.
Wyomissing, Pennsylvania, 19610
Cardiology Consultants of Philadelphia
Yardley, Pennsylvania, 19067
Michigan Heart, PC
Ypsilanti, Michigan, 48106
Aquilo Research
Yukon, Oklahoma, 73099
Cardiology Associates of SE Ohio, Inc
Zanesville, Ohio, 43701
Physicans Research, Inc.
Zanesville, Ohio, 43701
Poland62 sites
Oddział Kardiologii z Zakładem Diagnostyki Kardiologicznej, Samodzielny Publiczny Zakład Opieki Zdrowotnej, Wojewódzki Szpital im. dr J. Biziela,
Bydgoszcz, 85-168
NZOZ "Medicus" Jacek Kubica
Bydgoszcz, 85-435
Wojewódzki Szpital Meijski im. Biziela, Oddział Kardiologii - SPZOZ
Bydgoszcz, 85-826
Oddział Chorób Wewnętrzych i Kardiologii , ZOZ w Debicy
Dębica, 39-200
Zakład Opieki Zdrowotnej Trójmiejskie Centrum Medyczne Sp. z o.o
Gdansk, 80-437
Gabinet Kardiologiczny Medipuls
Gdynia, 81-423
Gabinet Kardiologiczno-Internistyczny
Gdynia, 81-472
Centrum Leczenia Chorób Cywilizacyjnych Oddz. Gdynia filla Fikakowo
Gdynia, 81-572
NZOZ Medicus, Poradnia Kardiologiczna
Gliwice, 44-100
Oddział Kardiologii i INK, SPZOZ nr 1
Gliwice, 44-100
Mazowieckie Centrum Badań Klinicznych Iwona Czajkowska, Monika Śmietańska s.c.
Grodzisk Mazowiecki, 05-825
Publiczny Specjalistyczny Zaklad Opieki Zdrowotnej Oddzial Kardiologiczny
Inowrocław, 88-100
Oddział Chorób Wewnętrznych i Farmakologii Klinicznej Samodzielny Publiczny Centralny Szpital Kliniczny im. Prof. Kornela Gibińskiego Śląskiego Uniwersytetu Medycznego w Katowicach
Katowice, 40-752
Szpital Specjalistyczny w Kościerzynie, Oddział Kardiologii
Kościerzyna, 83-400
Oddział Kardiologii, Szpital Specjalistyczny im. J. Dietla
Krakow, 31-121
"Klinika Choroby Wieńcowej Instytut Kardiologii, Collegium Medicum Uniwerytet Jagielloński
Krakow, 31-202
Oddzial Chorób Wewnętrznych III Szpital Specjalistyczny im.Stefana Zeromskiego, SPZOZ w Krakowie
Krakow, 31-913
Niepubliczny Zakład Opieki Zdrowotnej Specjalista Sp. z o.o.
Kutno, 99-300
Poradnia Kardiologiczna, Oddział Chorob Wewnetrznych Szpital Powiatowy w Limanowej
Limanowa, 34-600
Niepubliczny Zakład Opieki Zdrowotnej POLIMEDICA
Lodz, 90-302
All-Med Centrum Medyczne
Lodz, 94-050
Oddział Kardiologiczny Szpital Wojewódzki im. Kardynała Stefana Wyszyńskiego
Łomża, 18-404
Oddział Internistyczno-Kardiologiczny Samodzielny Publiczny Zakład Opieki Zdrowotnej
Lubartów, 21-100
"Oddzial Chorob Wewnetrznych i Kardiologii, Szpital Powiatowy im.Edmunda Biernackiego
Mielec, 39-300
Oddział Kardiologii, Nowa Sól
Nowa Sól, 67-100
ZOZ w Oławie, Oddział Chorób Wewnętrznych
Oława, 55-200
"Oddział Kardiologiczno-Internistyczny
Olsztyn, 10-045
"Oddział Kardiologiczny Publiczny Samodzielny ZOZ Wojewódzkie Centrum Medyczne
Opole, 45-418
Specjalistyczny Zakład Opieki Zdrowotnej Poradnia lekarzy specjalistów "Jantar"
Ostrów Wielkopolski, 63-400
II Oddział Wewnętrzny Samodzielny Publiczny Zakład Opieki Zdrowotnej
Pabianice, 95-200
"Samodzielny Szpital Wojewódzki im. Mikołaja Kopernika, Oddział Kardiologiczny
Piotrkow Trybunalski, 97-300
Wojewódzki Szpital Zespolony, Oddział Kardiologiczny
Płock, 09-400
Specjalistyczna Przychodnia Lekarska "Medikard"
Płock, 09-402
Medyczne Centrum Hetmańska, Indywiualna Specjalistyczna Praktyka Lekarska, Dr n. med. Piotr Leszczyński
Poznan, 60-218
Specjalistyczne Centrum Diagnostyczno-Lecznicze Bamberski Dwór
Poznan, 60-539
Oddział Wewnetrzny I, Szpital Kolejowy im. dr med. Włodzimierza Roeslera
Pruszków, 05-800
Samodzileny Publiczny Zakład Opieki Zdrowotnej w Puławach, Szpital Specjalistyczny
Puławy, 24-100
Zakład Hemodynamiki, Wojewódzki Szpital Specjalistyczny
Radom, 26-617
"Oddział Kardiologii z Pododdziałem Ostrych Zespołów Wieńcowych i z Ośrodkiem Implantacji Rozruszników Serca,
Rzeszów, 35-301
Oddział Kardiologii, SP ZZOZ Sandomierz
Sandomierz, 27-600
Oddział Kardiologiczny Wojewódzki Szpital Specjalistyczy w Siedlcach
Siedlce, 08-110
Oddział Kardiologii Samodzielny Publiczny Zakład Opieki Zdrowotnej w Sieradzu im. Kardynała Stefana Wyszyńskiego
Sieradz, 98-200
"Oddział Kardiologii, Wojewódzki Szpital Zespolony w Skierniewicach, "
Skierniewice, 96-100
NZOZ Przychodnia Zadebie, Przychodnia Kardiologiczna
Skierniewice, 96-100
"Oddział Kardiologii Inwazyjnej i Angiologii z Pr. Hemodynamiki
Stalowa Wola, 37-450
Szpital Specjalistyczny Św.Jana, Oddział Kardiologii,
Starogard Gdański, 83-200
Indywidualna Specjalistyczna Praktyka Lekarska
Szczecin, 71-531
Poradnia Kardiologiczna
Tarnów, 33-100
Specjalistyczny Gabinet Lekarski Internistyczno-Kardiologiczny-Cardiology
Tarnów, 33-100
Niepubliczny Zakład Opieki Zdrowotnej "Nasz Lekarz", Praktyka Grupowa Lekarzy Rodzinnych z Przychodnią Specjalistyczną
Torun, 87 100
Oddział Kardiologii Wojewódzki Szpital Zespolony
Torun, 87-100
"Oddział Kardiologiczny Wałbrzyski Ośrodek Kardiologii Interwencyjnej Specjalityczny Szpital im. Dr Alfreda Sokołowskiego
Wałbrzych, 58-309
Oddział Kardiologiczny Szpital Wolski im. dr Anny Gostyńskiej Samodzielny Publiczny Zakład Opieki Zdrowotnej
Warsaw, 01 - 211
Samodzielny Publiczny Centralny Szpital Kliniczny Akademii Medycznej w Warszawie
Warsaw, 02-097
II Klinika Choroby Wieńcowej Instytutu Kardiologii im. Prymasa Tysiaclecia Stefana Kardynala Wyszynskiego
Warsaw, 02-637
Centrum Leczenia Chorób Cywilizacyjnych
Warsaw, 02-777
Międzyleski Szpital Specjalistyczny w Warszawie
Warsaw, 04-749
NZOZ Starówka
Warsaw
Synexus SCM Sp.z o o.
Wroclaw, 50-088
Niepubliczny Zakład Opieki Zdrowotnej, Centrum Badań Klinicznych
Wroclaw, 50-349
Osrodek Chorob Serca, Klinika Kardiologii 4 Wojskowy Szpital Kliniczny z Poliklinika - Samodzielny Publiczny Zaklad Opieki Zdrowotnej
Wroclaw, 50-981
"Śląskie Centrum Chorób Serca, III Katedra i Oddział Kliniczny Kardiologii Śląskiego Uniwersytetu Medycznego
Zabrze, 41-800
Germany50 sites
Universitatsklinikum Berlin Campus Charite Mitte Med Klinik Kardiologie und Angiologie
Berlin, 10117
Vivantes Clinic Neuköln Berlin
Berlin, 12351
Vivantes Humbolt Klinikum
Berlin, 13509
Praxis Dr. med. Boscher
Biberach, 88400
St. Josef-Hospital Medizinische Klinik II, Kardiologie
Bochum, 44791
St.-Marien-Hospital Bonn
Bonn, 53115
Städtisches Klinikum Brandenburg GmbH
Brandenburg, 14770
MVZ am Küchwald GmbH
Chemnitz, 09113
Kliniken der Stadt Köln, Köln Merheim
Cologne, 53109
Gemeinschaftspraxis Innere Medizin und Kardiologie
Dinslaken, 46535
St.-Johannes-Hospital Dortmund
Dortmund, 44137
Zentrum für klinische Prüfungen in der Facharztzentrum Dresden Neustadt GbR
Dresden, 1099
Practice of Cardiology
Erfurt, 990804
Elisabeth.Krankenhaus
Essen, 45138
Asklepios Klinik St.Georg
Hamburg, 20099
Asklepios Klinik Barmbek
Hamburg, 22291
Universitäres Herz-und Gefäßzentrum Hamburg"
Hamburg, 22527
Kardiologische Praxis Hamburg Altona
Hamburg, 22765
Klinikum Region Hannover Krankenhaus Nordstadt
Hanover, 30167
Kardiologische Gemeinschaftspraxis
Hartmannsdorf, 09232
SRH Klinikum Karlsbad-Langensteinbach
Karlsbad, 76307
Herzzentrum Lahr
Lahr, 77933
Kardiologische Gemeinschaftpraxis
Leipzig, 04103
Universität Leipzig - Herzzentrum
Leipzig, 04289
Dr. THomas Klingenheben
Lengsdorf, 53127
Universitätsklinikum Lübeck
Lübeck, 23538
Praxis für Innere Medizin, Gastroenterologie
Ludwigshafen, 67067
Gemeinschaftspraxis
Lüneburg, 21339
Klinikum der Johannes-Gutenberg-Universität
Mainz, 55131
Gemeinschaftspraxis
Mannheim, 68165
Klinikum Mannheim GmbH, Universaitatskinikum
Mannheim, 68167
Kardiologische Praxis
Markkleeberg, 04416
Asklepios Klinik Melsungen
Melsungen, 34212
Kilniken Maria Hilf GmbH Krankenhaus St. Franziskus
Mönchengladbach, 41063
Internist/Kardiologe/Angiologe
Mühldorf A.d. Inn, 84453
Kardiologische Gemeinschaftspraxis
Nienburg, 31582
Klinikum Pirna GmbH
Pirna, 01796
Universitätsklinik Regensburg
Regensburg, 93053
Krankenhaus Reinbek St. Adolf-Stift
Reinbek, 21465
Kardiologische Gemeinschaftspraxis
Riesa, 01589
Internistische Praxis
Rottweil, 78628
Zentrum für Prävention und Rehabilation
Siegen, 57072
Marienkrankenhaus Soest
Soest, 59494
Praxisgemeinschaft Stuhr-Brinkum
Stuhr, 28816
Medizinische Universitätsklinik
Tübingen, 72076
Josephs-Hospital Warendorf
Warendorf, 48231
Kardiologische Praxis
Wermsdorf, 04779
Dr. Andreas Schreckenberg
Weyhe-Leeste, 28844
ForschungsZentrum Ruhr
Witten, 58455
Helios Klinikum Wuppertal
Wuppertal, 42117
Canada24 sites
Cambridge Cardiac Care Centre
Cambridge, Ontario, NIR-6V6
Recherches Cliniques Theradev
Granby, Quebec, J2G8Z9
ViaCar Recherche Clinique Inc.
Greenfield Park, Quebec, J4N1L6
ViaCar Recherche Clinique Inc
Longueuil, Quebec, J4N1L6
Dr. Tsui
Maple Ridge, British Columbia, V2X 5Z6
Mississauga Clinical Research Center
Mississauga, Ontario, L5B2P7
South East Regional Health Authority
Moncton, New Brunswick, E1C4B7
Hospitalier de l'Universite de Montreal Hotel Dieu
Montreal, Quebec, H2W 1T8
Sacre-Coeur Hospital
Montreal, Quebec, H4J1C5
Commonwealth Medical Clinic
Mount Pearl, Newfoundland and Labrador, A1N1W7
Fraser Clinical Trials Inc and Royal Columbian Hospital
New Westminster, British Columbia, V3L3W4
Dr. George Zimakas
Niagara Falls, Ontario, L2G5X7
Dr. James Y. Cha
Oshawa, Ontario, L1J2K1
Centre Hospitalier Universitaire de Quebec (CHOQ) Hotel Dieu de Quebec
Québec, Quebec, G1R2J6
Laval Hospital
Québec, Quebec, G1V4G5
Centre Hospitalier Beauce-Etchemin
Saint George, Quebec, G5Y5B7
Centre de Sante et de services sociaux du nord de lanaudiere/CHRDL
Saint-Charles-Borromée, Quebec, J6E6J2
Curans Health Center
Thunder Bay, Ontario, P7R2Z3
Toronto East Cardiology Associates Inc.
Toronto, Ontario, M4C-1N2
Clinique de Cardiologie de Trois-Rivieres
Trois-Rivières, Quebec, G8Z 3R9
Vancouver General Hospital
Vancouver, British Columbia, V5Z 1M9
Victoria Heart Institute Foundation
Victoria, British Columbia, V8R4R2
Cardiology and Research
Westmount, Quebec, H3Z2M6
Health Sciences Centre
Winnipeg, Manitoba, R3A1R9
Bulgaria13 sites
Multiprofile Hospital for Active Treatment "Sveta Ekaterina", 1st Department of Internal Diseases
Dimitrovgrad
Multiprofile Hospital for Active Treatment "Dr. Georgi Stranski, Clinic of Cardiology
Pleven
Multiprofile Hospital for Active Treatment ''Sveti Georgi'', Cardiology Clinic
Plovdiv
Multiprofile Hospital for Active Treatment ''Sveti Panteleymon'', 2nd Department. of Internal Diseases - Intensive Cardiology Unit
Plovdiv
Multiprofile Hospital for Active Treatment - Ruse, 4th Department of Internal Diseases
Rousse
4th Multiprofile Hospital for Active Treatment
Sofia
Military Medical Academy, Clinic of Cardiology and Intensive Care
Sofia
Multiprofile Hospital for Active Treatment and Emergency Medicine "Pirogov". Cardiology Clinic
Sofia
National Heart Hospital Department of Cardiology
Sofia
National Multiprofile Transport Hospital "Tsar Boris III, Cardiology Clinic
Sofia
Tokuda Hospital Department of Cardiology
Sofia
University Multiprofile Hospital for Active Treatment ''Tsaritsa Ioanna'' - ISUL, Cardiology Clinic
Sofia
Multiprofile Hospital for Active Treatment "Sveta Marina", Clinic of Internal Diseases - 2nd Internal Department
Varna
Australia12 sites
Wesley research institute
Auchenflower, Queensland, 4066
Cairns Base Hospital
Cairns, Queensland, 4870
Coffs Harbour Cardiology
Coffs Harbour, New South Wales, 2450
Cardiac Research Institute
Eastwood, New South Wales, 2122
Northern Hospital
Epping, Victoria, 3076
St.Vincent's Hospital (Melb)
Fitzroy, Victoria, 3065
Fremantle Hospital
Fremantle, Western Australia, 6160
The Canberra Hospital
Garran, Australian Capital Territory, 2605
Geelong Hospital- Barwon Health
Geelong, Victoria, 3220
Royal Brisbane and Women's Hospital
Herston, Queensland, 4029
Royal Hobart Hospital
Hobart, Tasmania, 7001
Launceston General Hospital
Launceston, Tasmania, 7250
Czechia11 sites
Nemocnice ve Frydku-Mistku
Frýdek-Místek, 738 18
Fakultni nemocnice Hradec Kralove
Hradec Králové, 500 05
Krajska nemocnice Liberec, a. s.
Liberec, 460 63
Litomyslska nemocnice a. s.
Litomyšl, 570 14
Kardiologická ambulance
Ostrava, 702 00
Kardiologicka a angiologicka ambulance
Ostrava Vítkovice, 703 00
Pardubicka krajska nemocnice, a.s.
Pardubice, 532 03
II.interni klinika kardiologie a angiologie 1. LF UK a VFN v Praze
Prague, 12808
Klinika kardiologie Institut klinické a experimentální medicíny
Prague, 140 21
Krajská nemocnice T. Bati a.s.
Zlín, 762 75
Nemocnice Znojmo, p.o.
Znojmo, 669 02
Slovakia11 sites
Novamed s.r.o.
Banská Bystrica, 97405
Alian s.r.o.
Bardejov, 085-01
5. Interna klinika LF UK, FNsP Bratislava, Nemocnica Ruzinov
Bratislava, 826 06
Cardio D&R spol. s r.o.
Košice, 040-22
Kardiomed s.r.o.
Lučenec, 98401
NZZ Kardiocentrum Nitra s.r.o.
Nitra, 950-01
MUDr. Tibor DURIS, CSc., s.r.o.
Nové Zámky, 94052
Nemocnica s poliklinikou Považská Bystrica
Považská Bystrica, 017 26
Fakultna Nemocnica Trencin
Trenčín, 911 71
Žilpo s.r.o.
Žilina, 010 01
Medivasa s.r.o.
Žilina, 010-01
Chile10 sites
Clinica Antofagasta
Antofagasta
Corporación de Beneficencia Osorno
Osorno
Hospital Regional de Punta Arenas Dr. Lautaro Navarro
Punta Arenas
Complejo Asistencial Dr.Sótero del Río
Santiago, 8207257
Hospital del Salvador
Santiago
Instituto Nacional del Tórax
Santiago
Centro de Estudios Cardiovascular
Temuco
Clínica Reñaca
Viña del Mar
Hospital Dr. Gustavo Fricke
Viña del Mar
Hospital Naval Almirante Neff
Viña del Mar
Romania10 sites
Spitalul Clinic Judetean de Urgenta Bacau
Bacau, 600114
S.C. Duo Medical S.R.L.
Bucharest, 010584
Centrul Medical SANA
Bucharest, 011025
Cardiomed SRL
Bucharest, 020506
Institutul Inimii "Niculae Stanicioiu"
Cluj-Napoca, 400001
Cardiomed SRL
Craiova, 200147
Dr. C.I. Parhon Hospital
Iași, 700503
Clinical county Hospital
Sibiu, 550245
Institutul de Boli Cardiovasculare si Transplan Tg. Mures
Târgu Mureş, 540136
County Hospital
Timișoara, 300736
France9 sites
Centre Hospitalier d'Albi
Albi, 81000
Centre de Cardiologie CHRU Dijon
Dijon, 21079
Clinique Pasteur
Essey-lès-Nancy, 54270
CHRU de Lille Hôpital Cardiologique
Lille, 59037
Hôpital La Timone-Adultes
Marseille, 13385
Hôpital Lariboisière
Paris, 75010
La Pitié Salpétrière Institut de Cardiologie
Paris, 75651
Centre Hospitalier Intercommunal du Val d'Ariège
Saint-Jean-de-Verges, 09000
Centre Hospitalier Rangueil Larrey
Toulouse, 31403
Hungary9 sites
Bajai Kórház
Baja, H-6500
Budai Irgalmasrendi Kórház
Budapest, H-1027
Fővárosi Önkormányzat Károlyi Sándor Kórház és Rendelőintézet
Budapest, H-1041
Fovarosi Onkormanyzat Egyesitett Szent Istvan es Szent Laszlo Korhaz - Rendelointezet
Budapest, H-1096
Városi Önkormányzat Kórház-Rendelőintézet
Kalocsa, H-6300
Szabolcs-Szatmár-Bereg Megyei Önkormányzat Jósa András Oktató Kórház
Nyíregyháza, H-4400
Jász-Nagykun-Szolnok Megyei Hetényi Géza Kórház
Toszegi, H-5004
Jávorszky Ödön Kórház
Vác, H-2600
Zala Megyei Kórház
Zalaegerszeg, H-8900
Mexico9 sites
Hospital Cardiológica Aguascalientes
Aguascalientes, 20230
Hospital de Jesus
D. F., D. F., cp 06090
Cardioprevent
Durango, C. P 34080
Hospital "Valentín Gómez Farías"
Guadalajara, Jalisco, 44600
Hospital Angeles de Puebla
Puebla City, 72190'
Hospital General de Puebla
Puebla City, 72490
Instituto de Corazón de Querétaro, S.A. de C.V.
Querétaro City, Querétaro, 76178
Cardioarritmias e Investigación, S.C.
San Luis Potosí City, San Lusi Potosi, 78200
Hospital Central "Dr. Ignacio Morones Prieto"
San Luis Potosí City, 78240
Ukraine7 sites
"Klinichne obyednannia shvydkoi medychnoi dopomogy, m. Dnipropetrovs'k,Dnipropetrovs'ka derzhavna medychna akademiya, kafedra gospital'noi terapii #2
Dnipropetrovsk, 49006
Oblasnyi klinichnyi kardiologichnyi dyspanser, m. Ivano-Frankivsk, Ivano-Frankivskyi derzhavnyi medychnyi universytet, kafedra terapii # 3
Ivano-Frankivsk, 76005
TOV "Kardiologichna klinika "Sertse i sudyny" m. Kyiv
Kyiv, 1032
Natsionalnyi naukovyi tsentr "Instytut kardiologii im. akad. M.D. Strazheska" AMN Ukrainy, m. Kyiv, viddilenia symptomatychnykh arterial'nykh gipertenziy
Kyiv, 3680
Natsionalnyi naukovyi tsentr "Instytut kardiologii im. akad. M.D. Strazheska", viddil reanimatsii ta intensyvnoi terapii, m. Kyiv
Kyiv, 3680
Komunal'na ustanova "Oblasnyi kardiologichnyi dyspanser", viddilenia intensyvnoi terapii, m. Zaporizhzhia
Zaporizhzhya, 69000
Kardioarytmologichnyi tsentr Zhytomyrs'koi oblasnoi klinichnoi likarni im. O.F. Gorbachevs'kogo, m. Zhytomyr
Zhytomyr, 10002
Italy6 sites
Ospedali Riuniti di bergamo
Bergamo, 24128
Azienda Ospedaliera della Provincia di Lodi Presidio Ospedaliero di Codogno
Codogno (Lodi), 26845
Azienda Ospedaliera Universitaria San Martino-Dipartimento di Medicina Interna e Specialità Mediche
Genova, 16132
Azienda Ospeedaliera Carlo Poma
Mantua, 46100
Azienda Ospedaliera Maggiore Della Carita' Di Novara
Novara, 28100
Istituto Clinico Humanitas
Rozzano (Milano), 20089
About this study
Official title: A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease
The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of gastrointestinal bleeding and symptomatic ulcer disease, in the setting of concomitant aspirin therapy.
Antiplatelet therapy is an essential element of care for patients with atherothrombotic disease. Bleeding is a fundamental adverse effect of all antiplatelet drugs including aspirin, clopidogrel and dual antiplatelet regimens.
Read more
The gastrointestinal tract is the most common site of bleeding related to antiplatelet therapy, typically in connection with peptic ulcer disease. Recently published studies suggest the use of clopidogrel carries a gastrointestinal bleeding risk similar to that of aspirin or non-aspirin non-steroidal anti-inflammatory drugs. Patients taking any two of these drugs (clopidogrel, aspirin and/or non-aspirin NSAIDs) are exposed to an even higher risk of bleeding and ulcer disease.
Cogentus Pharmaceuticals is launching phase 3 trials of a novel combination product, CGT-2168, which has the potential to significantly reduce this problem and increase patient safety. CGT-2168 combines a standard dosage of clopidogrel and a gastroprotectant (omeprazole) in a once-daily pill that may reduce the likelihood of adverse gastrointestinal events.
- Conditions
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
- Being tested
- CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin, Plavix (clopidogrel 75 mg) and aspirin
- Keywords
- ACS, CAD, MI, PCI, PTCA, NSTEMI, STEMI, acute coronary syndrome, cerebrovascular disorders, coronary artery stent placement, coronary thrombosis, myocardial infarction, myocardial ischemia, percutaneous coronary intervention, percutaneous transluminal coronary angioplasty, peripheral vascular diseases, duodenal obstruction, duodenal ulcer, dyspepsia, esophagitis, peptic
- Medical subject headings
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Non-ST Elevated Myocardial Infarction, ST Elevation Myocardial Infarction, Cerebrovascular Disorders, Coronary Thrombosis, Myocardial Ischemia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirinDrug
(CGT-2168 active and Comparator placebo, one capsule each daily; and enteric coated aspirin at daily dose level assigned by study physician)
Plavix (clopidogrel 75 mg) and aspirinDrug
(CGT-2168 placebo and Comparator active, one capsule each daily; and enteric coated aspirin at daily dose level assigned by study physician)
| Study group | Role | What they receive |
|---|---|---|
| 1 | Experimental | Not described Receives: Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin |
| 2 | Active comparator | Not described Receives: Drug: Plavix (clopidogrel 75 mg) and aspirin |
What is being measured
The primary outcome is the main question the study is designed to answer.
Composite of upper gastrointestinal clinical events, including gastroduodenal bleeding, symptomatic gastroduodenal ulcer, persistent pain with multiple gastric erosions, obstruction or perforation
Measured: Anticipated minimum of 48 weeks, up to end of study
Secondary outcomes (6)
Composite of gastroduodenal bleeding, symptomatic gastroduodenal ulcer, obstruction or perforation
Measured: Anticipated minimum of 48 weeks, up to end of study
Composite of gastroduodenal bleeding, obstruction or perforation
Measured: Anticipated minimum of 48 weeks, up to end of study
Discontinuation of study medication attributed to gastrointestinal signs or symptoms
Measured: Anticipated minimum of 48 weeks, up to end of study
Gastroesophageal reflux disease, as evidenced by symptomatic endoscopically-confirmed erosive esophagitis
Measured: Anticipated minimum of 48 weeks, up to end of study
Dyspepsia, defined as an increase of at least ten points on the "pain intensity" component of the SODA instrument from baseline
Measured: Anticipated minimum of 48 weeks, up to end of study
Occurrence of a cardiovascular event (cardiovascular death, nonfatal myocardial infarction, CABG or PCI, or confirmed ischemic stroke
Measured: Anticipated minimum of 48 weeks, up to end of study
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted14 Nov 2007 (estimated)
- Study startDec 2007
- Primary completionNov 2009 (estimated)
- Study completionNov 2009 (estimated)
Why it stopped: Terminated by Sponsor
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (2)Papers the sponsor has linked to this study.
- Other trials for Acute Coronary SyndromeStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 3
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind
- Who is masked
- Participant, Investigator, Outcomes assessor
- Enrolment
- 5,000 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cogentus Pharmaceuticals
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Pablo Lapuerta, MD, Study director, Cogentus Pharmaceuticals
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00557921
- Sponsor's protocol ID
- CG104
- Other IDs
- EudraCT 2007-005891-15
- Acronym
- COGENT-1
- Status last verified
- Jan 2009
- First submitted
- 12 Nov 2007
- Last updated
- 28 Jan 2009
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP; COGENT Investigators. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. J Am Coll Cardiol. 2016 Apr 12;67(14):1661-71. doi: 10.1016/j.jacc.2015.12.068. Epub 2016 Mar 21.
PubMed 27012778Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6.
PubMed 20925534
Study at a glance
From the registry record, last updated by the sponsor on 28 Jan 2009. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- A Randomized, Double-Blind, Double-Dummy, Parallel Group, Phase 3 Efficacy and Safety Study of CGT-2168 Compared With Clopidogrel to Reduce Upper Gastrointestinal Events Including Bleeding and Symptomatic Ulcer Disease
- ClinicalTrials.gov ID
- NCT00557921
- Acronym / sponsor ID
- COGENT-1 / CG104
- Conditions
- Acute Coronary Syndrome, Myocardial Infarction, Coronary Artery Disease, Percutaneous Coronary Intervention
- Keywords
- ACS, CAD, MI, PCI, PTCA, NSTEMI, STEMI, acute coronary syndrome
- Phase
- Phase 3
- Study type
- Interventional
- Recruitment status
- TerminatedReason stopped: Terminated by Sponsor
- Enrolment
- 5,000 participants (estimated)
- Lead sponsor
- Cogentus PharmaceuticalsIndustry (pharma, biotech, devices)
- Study start
- Dec 2007
- Primary completion
- Nov 2009 (estimated)
- Study completion
- Nov 2009 (estimated)
- First posted
- 14 Nov 2007 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of the COGENT-1 clinical trial is to determine whether CGT-2168 (clopidogrel and omeprazole) compared to clopidogrel is safe and effective in reducing the incidence of gastrointestinal bleeding and symptomatic ulcer disease, in the setting of concomitant aspirin therapy.
Antiplatelet therapy is an essential element of care for patients with atherothrombotic disease. Bleeding is a fundamental adverse effect of all antiplatelet drugs including aspirin, clopidogrel and dual antiplatelet regimens.
The gastrointestinal tract is the most common site of bleeding related to antiplatelet therapy, typically in connection with peptic ulcer disease. Recently published studies suggest the use of clopidogrel carries a gastrointestinal bleeding risk similar to that of aspirin or non-aspirin non-steroidal anti-inflammatory drugs. Patients taking any two of these drugs (clopidogrel, aspirin and/or non-aspirin NSAIDs) are exposed to an even higher risk of bleeding and ulcer disease.
Cogentus Pharmaceuticals is launching phase 3 trials of a novel combination product, CGT-2168, which has the potential to significantly reduce this problem and increase patient safety. CGT-2168 combines a standard dosage of clopidogrel and a gastroprotectant (omeprazole) in a once-daily pill that may reduce the likelihood of adverse gastrointestinal events.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Triple blind (participant, investigator, outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| 1 | Experimental | Drug: CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin |
| 2 | Active comparator | Drug: Plavix (clopidogrel 75 mg) and aspirin |
Who may qualify
- Ages
- 21 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Patients in whom a requirement for clopidogrel therapy with concomitant aspirin is anticipated for at least the next 12 months. Specific conditions that may confer a need for long-term clopidogrel + aspirin therapy may include non-ST segment elevation acute coronary syndrome (unstable angina/non-Q-wave MI), ST segment elevation acute MI), or new placement of a coronary artery stent.
- For women of childbearing potential, negative pregnancy test prior to randomization and agreement to use effective method of birth control during the study.
- Able to provide written informed consent based on competent mental status.
Key exclusion criteria (17 listed)
- Patients currently hospitalized for whom discharge is not anticipated within 48 hours of randomization.
- Requirement for current or chronic use of a proton pump inhibitor, H2 receptor blocker, sucralfate or misoprostol.
- Erosive esophagitis, esophageal or gastric variceal disease, or non-endoscopic gastric surgery. Patients with a history of GERD/erosive esophagitis or dyspepsia who do not currently require proton pump blockers will be eligible.
- Receipt of > 21 days of clopidogrel or another thienopyridine prior to randomization.
- Oral anticoagulation that cannot be safely discontinued for duration of study.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin(CGT-2168 active and Comparator placebo, one capsule each daily; and enteric coated aspirin at daily dose level assigned by study physician) | Drug | 1 |
| Plavix (clopidogrel 75 mg) and aspirin(CGT-2168 placebo and Comparator active, one capsule each daily; and enteric coated aspirin at daily dose level assigned by study physician) | Drug | 2 |
Primary outcome
Composite of upper gastrointestinal clinical events, including gastroduodenal bleeding, symptomatic gastroduodenal ulcer, persistent pain with multiple gastric erosions, obstruction or perforation
Time frame: Anticipated minimum of 48 weeks, up to end of study
6 secondary outcomes
Composite of gastroduodenal bleeding, symptomatic gastroduodenal ulcer, obstruction or perforation
Time frame: Anticipated minimum of 48 weeks, up to end of study
Composite of gastroduodenal bleeding, obstruction or perforation
Time frame: Anticipated minimum of 48 weeks, up to end of study
Discontinuation of study medication attributed to gastrointestinal signs or symptoms
Time frame: Anticipated minimum of 48 weeks, up to end of study
Gastroesophageal reflux disease, as evidenced by symptomatic endoscopically-confirmed erosive esophagitis
Time frame: Anticipated minimum of 48 weeks, up to end of study
Dyspepsia, defined as an increase of at least ten points on the "pain intensity" component of the SODA instrument from baseline
Time frame: Anticipated minimum of 48 weeks, up to end of study
Occurrence of a cardiovascular event (cardiovascular death, nonfatal myocardial infarction, CABG or PCI, or confirmed ischemic stroke
Time frame: Anticipated minimum of 48 weeks, up to end of study
Results and safety
The study was stopped early (reason given: Terminated by Sponsor). Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 28 Jan 2009.
- Derived from this study: PubMed 27012778Vaduganathan M, Bhatt DL, Cryer BL, Liu Y, Hsieh WH, Doros G, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Cannon CP; COGENT Investigators. Proton-Pump Inhibitors Reduce Gastrointestinal Events Regardless of Aspirin Dose in Patients Requiring Dual Antiplatelet Therapy. J Am Coll Cardiol. 2016 Apr 12;67(14):1661-71. doi: 10.1016/j.jacc.2015.12.068. Epub 2016 Mar 21.
- Derived from this study: PubMed 20925534Bhatt DL, Cryer BL, Contant CF, Cohen M, Lanas A, Schnitzer TJ, Shook TL, Lapuerta P, Goldsmith MA, Laine L, Scirica BM, Murphy SA, Cannon CP; COGENT Investigators. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med. 2010 Nov 11;363(20):1909-17. doi: 10.1056/NEJMoa1007964. Epub 2010 Oct 6.
Related trials for Acute Coronary Syndrome
Recruiting
CT Stress Myocardial Perfusion, Fractional Flow Reserve and Angiography in Patients With Stable Chest Pain Syndromes
Coronary Artery Disease, Chest Syndrome
Recruiting
WIN Ratio Analysis to Determine a Strategy of Non- Invasive SUpport for Respiratory Failure in the EmeRgency Department
Acute Hypoxic Respiratory Failure, Acute Respiratory Distress Syndrome (ARDS)
RecruitingPhase 4
Early Single Antiplatelet Therapy After IVUS-Guided PCI in Acute Coronary Syndrome
Acute Coronary Syndromes, STEMI
Recruiting
AI-Assisted Interpretation of Cardiac CT in the Emergency Department
Chest Pain, Acute Coronary Syndrome
Enrolling by invitation
Optical Coherence Tomography in Acute Vessel Evaluation
Ischemic Heart Disease, Ischemic Coronary Artery Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Pablo Lapuerta, MD study director
Cogentus Pharmaceuticals
491 sites in 16 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 3 study testing CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin and Plavix (clopidogrel 75 mg) and aspirin in people with Acute Coronary Syndrome and Myocardial Infarction, run by Cogentus Pharmaceuticals at 491 sites in 16 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: stopped early, as of the sponsor's last update on 28 Jan 2009. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 491 sites in United States, Poland, Germany, Canada, Bulgaria and 11 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 3 studies compare the treatment with the current standard treatment or a placebo in a large group, to confirm how well it works and watch for side effects.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
The study was stopped early (reason given: Terminated by Sponsor). Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Composite of upper gastrointestinal clinical events, including gastroduodenal bleeding, symptomatic gastroduodenal ulcer, persistent pain with multiple gastric erosions, obstruction or perforation (time frame: Anticipated minimum of 48 weeks, up to end of study). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00557921, which also lists 2 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 28 Jan 2009.